Published in J Psychiatry Neurosci on September 01, 2001
Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes. Alcohol Clin Exp Res (2008) 1.43
Polymorphisms of the mu-opioid receptor and dopamine D4 receptor genes and subjective responses to alcohol in the natural environment. J Abnorm Psychol (2010) 1.37
A microdialysis profile of beta-endorphin and catecholamines in the rat nucleus accumbens following alcohol administration. Psychopharmacology (Berl) (2003) 1.23
Alcoholism: the dissection for endophenotypes. Dialogues Clin Neurosci (2005) 1.16
Nalmefene: a new approach to the treatment of alcohol dependence. Subst Abuse Rehabil (2014) 1.10
Deletion of agouti-related protein blunts ethanol self-administration and binge-like drinking in mice. Genes Brain Behav (2009) 0.99
The long-lasting effects of JDTic, a kappa opioid receptor antagonist, on the expression of ethanol-seeking behavior and the relapse drinking of female alcohol-preferring (P) rats. Pharmacol Biochem Behav (2012) 0.92
Mu (mu) opioid receptor regulation of ethanol-induced dopamine response in the ventral striatum: evidence of genotype specific sexual dimorphic epistasis. Biol Psychiatry (2007) 0.91
Potency of naltrexone to reduce ethanol self-administration in rats is greater for subcutaneous versus intraperitoneal injection. Alcohol (2009) 0.88
Pharmacologic dissociation between impulsivity and alcohol drinking in high alcohol preferring mice. Alcohol Clin Exp Res (2010) 0.87
Pharmacogenetic studies of alcohol self-administration and withdrawal. Psychopharmacology (Berl) (2003) 0.86
Pharmacological approaches to reducing craving in patients with alcohol use disorders. CNS Drugs (2014) 0.86
Effects of alcohol on the endocrine system. Endocrinol Metab Clin North Am (2013) 0.85
Attenuated beta endorphin response to acute stress is associated with smoking relapse. Pharmacol Biochem Behav (2008) 0.85
Ethanol-induced increase of agouti-related protein (AgRP) immunoreactivity in the arcuate nucleus of the hypothalamus of C57BL/6J, but not 129/SvJ, inbred mice. Alcohol Clin Exp Res (2010) 0.84
Naloxone does not attenuate the locomotor effects of ethanol in FAST, SLOW, or two heterogeneous stocks of mice. Psychopharmacology (Berl) (2005) 0.84
Effects of acute ethanol on beta-endorphin release in the nucleus accumbens of selectively bred lines of alcohol-preferring AA and alcohol-avoiding ANA rats. Psychopharmacology (Berl) (2009) 0.82
Beta-endorphin mediates behavioral despair and the effect of ethanol on the tail suspension test in mice. Alcohol Clin Exp Res (2010) 0.81
Interrelations between pain and alcohol: An integrative review. Clin Psychol Rev (2015) 0.81
Cyclo-glycyl-glutamine inhibits ethanol intake in P and Sprague-Dawley rats. Peptides (2007) 0.80
Decreased immunoreactivity of the polypeptide precursor pro-opiomelanocortin (POMC) and the prohormone convertase pc1/3 after chronic ethanol exposure in Sprague-Dawley rats. Alcohol Clin Exp Res (2012) 0.80
Endogenous opioids as substrates for ethanol intake in the neonatal rat: The impact of prenatal ethanol exposure on the opioid family in the early postnatal period. Physiol Behav (2015) 0.79
Evidence that Melanocortin Receptor Agonist Melanotan-II Synergistically Augments the Ability of Naltrexone to Blunt Binge-Like Ethanol Intake in Male C57BL/6J Mice. Alcohol Clin Exp Res (2015) 0.79
Alcohol enhances HIV infection of cord blood monocyte-derived macrophages. Curr HIV Res (2014) 0.78
Involvement of the endogenous opioid system in the psychopharmacological actions of ethanol: the role of acetaldehyde. Front Behav Neurosci (2013) 0.77
Systemic and intra-accumbens microinjections of naltrexone interfere with tolerance to ethanol in rats. Psychopharmacology (Berl) (2005) 0.76
Involvement of delta opioid receptors in alcohol withdrawal-induced mechanical allodynia in male C57BL/6 mice. Drug Alcohol Depend (2016) 0.75
Involvement of the beta-endorphin neurons of the hypothalamic arcuate nucleus in ethanol-induced place preference conditioning in mice. Alcohol Clin Exp Res (2011) 0.75
Role of exercise in the treatment of alcohol use disorders. Biomed Rep (2016) 0.75
Sex differences in the effects of adolescent social deprivation on alcohol consumption in μ-opioid receptor knockout mice. Psychopharmacology (Berl) (2014) 0.75
The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. JAMA (1991) 5.84
Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry (1992) 5.48
Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA (1990) 5.04
Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci (1992) 4.57
Cloning and sequence analysis of cDNA for porcine beta-neo-endorphin/dynorphin precursor. Nature (1982) 3.09
Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci U S A (1992) 3.02
The dopamine hypothesis of reward: past and current status. Trends Neurosci (1999) 2.68
Endogenous opioids: biology and function. Annu Rev Neurosci (1984) 2.54
Neurocircuitry targets in ethanol reward and dependence. Alcohol Clin Exp Res (1998) 2.38
Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther (1988) 2.29
Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens. J Neurosci (1998) 2.12
Endogenous opioid systems and alcohol addiction. Psychopharmacology (Berl) (1997) 2.11
Event-related brain potentials in boys at risk for alcoholism. Science (1984) 2.10
The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J Neurochem (1990) 1.71
Pain sensitivity, mood and plasma endocrine levels in man following long-distance running: effects of naloxone. Pain (1984) 1.70
Pharmacotherapies for alcohol problems: a review of research with focus on developments since 1991. Alcohol Clin Exp Res (1996) 1.61
No association between an allele at the D2 dopamine receptor gene (DRD2) and alcoholism. JAMA (1991) 1.56
Thirty-two years of selection of rats by ethanol preference: UChA and UChB strains. Neurobehav Toxicol Teratol (1983) 1.39
Differences in platelet enzyme activity between alcoholics and nonalcoholics. N Engl J Med (1988) 1.31
Alcohol self-administration: further examination of the role of dopamine receptors in the nucleus accumbens. Alcohol Clin Exp Res (1997) 1.29
Enhanced sensitivity of pituitary beta-endorphin to ethanol in subjects at high risk of alcoholism. Arch Gen Psychiatry (1996) 1.26
Alteration of ethanol self-administration by naltrexone. Life Sci (1980) 1.23
Naltrexone alters subjective and psychomotor responses to alcohol in heavy drinking subjects. Neuropsychopharmacology (2000) 1.22
Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial. Neuropsychopharmacology (2000) 1.19
Ethanol and negative feedback regulation of mesolimbic dopamine release in rats. Psychopharmacology (Berl) (1998) 1.17
Central administration of an opiate antagonist decreases oral ethanol self-administration in rats. Alcohol Clin Exp Res (1999) 1.15
The effects of 6-hydroxydopamine lesions of the nucleus accumbens and the mesolimbic dopamine system on oral self-administration of ethanol in the rat. Brain Res (1993) 1.14
Biosynthesis of beta-endorphin from beta-lipotropin and a larger molecular weight precursor in rat pars intermedia. Proc Natl Acad Sci U S A (1978) 1.11
Bidirectional selection for susceptibility to ethanol withdrawal seizures in Mus musculus. Behav Genet (1985) 1.10
Ethanol withdrawal in mice bred to be genetically prone or resistant to ethanol withdrawal seizures. J Pharmacol Exp Ther (1986) 1.10
Naltrexone, relapse prevention, and supportive therapy with alcoholics: an analysis of patient treatment matching. J Consult Clin Psychol (1996) 1.09
Genetic selection for voluntary alcohol consumption in the albino rat. Science (1968) 1.08
Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference. Pharmacol Biochem Behav (1990) 1.07
Importance of delta opioid receptors in maintaining high alcohol drinking. Psychopharmacology (Berl) (1991) 1.07
Reactions to alcohol in sons of alcoholics and controls. Alcohol Clin Exp Res (1988) 1.06
Basal and adenosine receptor-stimulated levels of cAMP are reduced in lymphocytes from alcoholic patients. Proc Natl Acad Sci U S A (1987) 1.06
A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence. Alcohol Clin Exp Res (1994) 1.04
Family history of alcoholism and hypothalamic opioidergic activity. Arch Gen Psychiatry (1998) 1.03
Effect of mu opioid receptor blockade on alcohol intake in rats bred for high alcohol drinking. Pharmacol Biochem Behav (1998) 1.03
The effect of repeated administration of morphine, cocaine and ethanol on mu and delta opioid receptor density in the nucleus accumbens and striatum of the rat. Neuroscience (1999) 1.03
Genetic selection and characterization of mouse lines for acute functional tolerance to ethanol. J Pharmacol Exp Ther (1996) 1.02
The endorphins: a growing family of pharmacologically pertinent peptides. Annu Rev Pharmacol Toxicol (1983) 1.01
Genetics of alcoholism: rapid development of a new high-ethanol-preferring (HEP) strain of female and male rats. Alcohol (1998) 0.99
The delta opioid receptor antagonist naltrindole attenuates both alcohol and saccharin intake in rats selectively bred for alcohol preference. Psychopharmacology (Berl) (1995) 0.99
Involvement of mu-opioid receptors in alcohol drinking by alcohol-preferring AA rats. Pharmacol Biochem Behav (1993) 0.99
Genetic differences in hypothalamic-pituitary-adrenal axis responsiveness to acute ethanol and acute ethanol withdrawal. Brain Res (1992) 0.99
Occupational stress factors and alcohol-related behavior in urban transit operators. Alcohol Clin Exp Res (2000) 0.98
Free-choice responding for ethanol versus water in alcohol preferring (P) and unselected Wistar rats is differentially modified by naloxone, bromocriptine, and methysergide. Psychopharmacology (Berl) (1990) 0.97
Different pituitary beta-endorphin and adrenal cortisol response to ethanol in individuals with high and low risk for future development of alcoholism. Life Sci (1989) 0.96
Central deficiency of beta-endorphin in alcohol addicts. J Clin Endocrinol Metab (1982) 0.96
Characterization of the effects of acute ethanol administration on the release of beta-endorphin peptides by the rat hypothalamus. Eur J Pharmacol (1990) 0.96
Opioid propeptide mRNA content and receptor density in the brains of AA and ANA rats. Life Sci (2000) 0.96
6-OHDA-lesions of the nucleus accumbens disrupt the acquisition but not the maintenance of ethanol consumption in the alcohol-preferring P line of rats. Alcohol Clin Exp Res (1997) 0.96
Comparison of the proopiomelanocortin and proenkephalin opioid peptide systems in brain regions of the alcohol-preferring C57BL/6 and alcohol-avoiding DBA/2 mice. Alcohol (1999) 0.96
Content of dynorphins and kappa-opioid receptors in distinct brain regions of C57BL/6 and DBA/2 mice. Alcohol Clin Exp Res (1997) 0.95
Ethanol oral self-administration is increased in mutant mice with decreased beta-endorphin expression. Brain Res (1999) 0.94
Oral ethanol-reinforced responding in rhesus monkeys: effects of opioid antagonists selective for the mu-, kappa-, or delta-receptor. Alcohol Clin Exp Res (1998) 0.94
Intravenous self-administration of ethanol in beta-endorphin-deficient mice. Alcohol Clin Exp Res (1998) 0.94
The delta 2-opioid receptor antagonist naltriben selectively attenuates alcohol intake in rats bred for alcohol preference. Pharmacol Biochem Behav (1995) 0.94
Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys. Psychopharmacology (Berl) (1991) 0.93
Voluntary consumption of ethanol in WSP, WSC and WSR selectively bred mouse lines. Pharmacol Biochem Behav (1988) 0.92
Differences in the opioid system in selected brain regions of alcohol-preferring and alcohol-nonpreferring rats. Alcohol Clin Exp Res (1999) 0.92
Acute alcohol effects on opiomelanocortinergic regulation. Alcohol Clin Exp Res (1998) 0.92
Medical management of alcohol dependence: clinical use and limitations of naltrexone treatment. Alcohol Alcohol (1995) 0.92
Effects of single and repeated exposures to ethanol on hypothalamic beta-endorphin and CRH release by the C57BL/6 and DBA/2 strains of mice. Neuroendocrinology (1993) 0.92
Subtypes of alcoholism and their role in therapy. Alcohol Alcohol (1996) 0.91
Effect of acute ethanol in vivo and in vitro on the beta-endorphin system in the rat. Life Sci (1987) 0.90
The alcohol-preferring C57BL/6 mice present an enhanced sensitivity of the hypothalamic beta-endorphin system to ethanol than the alcohol-avoiding DBA/2 mice. J Pharmacol Exp Ther (1992) 0.90
Suppression of alcohol intake by chronic naloxone treatment in P rats: tolerance development and elevation of opiate receptor binding. Alcohol Clin Exp Res (1999) 0.90
Quantitative autoradiography of mu-opioid receptors in the CNS of alcohol-naive alcohol-preferring P and -nonpreferring NP rats. Alcohol (1998) 0.90
Psychopathology in adopted-out children of alcoholics. The Stockholm Adoption Study. Recent Dev Alcohol (1985) 0.89
Multiple opiate receptors: alcohol selectively inhibits binding to delta receptors. Science (1981) 0.89
Mmu and D2 receptor antisense oligonucleotides injected in nucleus accumbens suppress high alcohol intake in genetic drinking HEP rats. Alcohol (1999) 0.89
Characterization of the forms of beta-endorphin and alpha-MSH in the caudal medulla of the rat and guinea pig. Brain Res (1986) 0.89
Mice genetically selected for differences in open-field activity after ethanol. Pharmacol Biochem Behav (1987) 0.88
A risk-benefit assessment of naltrexone in the treatment of alcohol dependence. Drug Saf (1996) 0.88
Opioid antagonists in the treatment of alcohol dependence: clinical efficacy and prevention of relapse. Alcohol Alcohol (1996) 0.88
Blockade of delta-opioid receptors in the nucleus accumbens prevents ethanol-induced stimulation of dopamine release. Eur J Pharmacol (1993) 0.87
Acute and chronic ethanol treatment changes endorphin levels in brain and pituitary. Psychopharmacology (Berl) (1980) 0.87
Ethanol modulation of opiate receptors in cultured neural cells. Science (1983) 0.87
Alcohol drinking is reduced by a mu 1- but not by a delta-opioid receptor antagonist in alcohol-preferring rats. Eur J Pharmacol (1996) 0.86
Acamprosate, but not naltrexone, inhibits conditioned abstinence behaviour associated with repeated ethanol administration and exposure to a plus-maze. Psychopharmacology (Berl) (2000) 0.86
Genetic serotonin deficiency and alcohol preference in the fawn hooded rats. Alcohol Alcohol (1990) 0.86
Proopiomelanocortin messenger RNA is decreased in the mediobasal hypothalamus of rats made dependent on ethanol. Alcohol Clin Exp Res (1992) 0.86
The influence of opioid antagonists on the discriminative stimulus effects of ethanol. Pharmacol Biochem Behav (1996) 0.85
Modulation of volitional ethanol intake in the rat by central delta-opioid receptors. Alcohol Clin Exp Res (1998) 0.85
Differences in the kappa opioid receptor mRNA content in distinct brain regions of two inbred mice strains. Neuroreport (1998) 0.85
Alcohol interactions with brain opiate receptors. Life Sci (1983) 0.85
Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey. Alcohol (1987) 0.85
Combination pharmacotherapy: a mixture of small doses of naltrexone, fluoxetine, and a thyrotropin-releasing hormone analogue reduces alcohol intake in three strains of alcohol-preferring rats. Alcohol Alcohol (2000) 0.85
Single-dose ethanol administration activates the hypothalamic-pituitary-adrenal axis: exploration of the mechanism of action. Neuroendocrinology (1989) 0.85
Differential effects of acute and chronic ethanol treatment on particular opioid peptide systems in discrete regions of rat brain and pituitary. Pharmacol Biochem Behav (1983) 0.85
Ethanol exposure decreases pituitary corticotropin-releasing factor binding, adenylate cyclase activity, proopiomelanocortin biosynthesis, and plasma beta-endorphin levels in the rat. Endocrinology (1986) 0.84
Sensitivity and tolerance to ethanol in mice bred to be genetically prone or resistant to ethanol withdrawal seizures. J Pharmacol Exp Ther (1986) 0.84
A small dose of morphine leads rats to drink more alcohol and achieve higher blood alcohol concentrations. Alcohol Clin Exp Res (1993) 0.84
Analysis of heritability of hormonal responses to alcohol in twins: beta-endorphin as a potential biomarker of genetic risk for alcoholism. Alcohol Clin Exp Res (2000) 0.84
Spontaneous and ethanol-stimulated in vitro release of beta-endorphin by the hypothalamus of AA and ANA rats. Alcohol Clin Exp Res (1994) 0.84
Differences between alcohol-preferring (AA) and alcohol-avoiding (ANA) rats in the prodynorphin and proenkephalin systems. Alcohol Clin Exp Res (1994) 0.83
Enhanced sensitivity of the nucleus accumbens proenkephalin system to alcohol in rats selectively bred for alcohol preference. Brain Res (1998) 0.83
Alcohol and the opiate receptor. Alcohol Clin Exp Res (1983) 0.83